SPOTLIGHT: Arixtra gets positive review in Europe


The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended that GlaxoSmithKline's Arixtra be approved for the prevention of venous thromboembolism in patients undergoing abdominal surgery who are at risk of thromboembolic complications. Release

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.